tiprankstipranks
Lantern Pharma, Inc. (LTRN)
NASDAQ:LTRN
US Market
LTRN
Lantern Pharma
RESEARCH TOOLSreports
Want to see LTRN full AI Analyst Report?

Lantern Pharma (LTRN) Income Statement

323 Followers

Lantern Pharma Income Statement

Last quarter (Q4 2025), Lantern Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Lantern Pharma's net income was $-4.07M. See Lantern Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -17.28K$ 0.00$ -174.84K$ 0.00$ 0.00
Operating Expenses
$ 17.98M$ 22.22M$ 17.70M$ 14.43M$ 12.59M
Depreciation and Amortization
$ 17.28K$ 17.28K$ 174.84K$ 10.08K$ 6.76K
EBITDA
$ -17.96M$ -22.20M$ -15.79M$ -14.42M$ -12.58M
Operating Income
$ -17.98M$ -22.22M$ -17.88M$ -14.43M$ -12.59M
Other Income/Expenses
$ 859.06K$ 1.44M$ 1.92M$ 172.81K$ 228.48K
Pretax Income
$ -17.12M$ -20.78M$ -15.96M$ -14.26M$ -12.36M
Net Income
$ -17.12M$ -20.78M$ -15.96M$ -14.26M$ -12.36M
Per Share Metrics
Basic EPS
$ -1.57$ -1.93K$ -1.47$ -1.31$ -1.13
Diluted EPS
$ -1.57$ -1.93K$ -1.47$ -1.31$ -1.13
Weighted Average Shares Outstanding
 10.90M 10.76M 10.84M 10.85M 10.90M
Weighted Average Shares Outstanding (Diluted)
 10.90M 10.76M 10.84M 10.85M 10.90M
Currency in USD

Lantern Pharma Earnings and Revenue History